Akkermansia muciniphila and its role in regulating host functions

Microbial Pathogenesis

Volumn 106, Issue , 2017, Pages 171-181

  Derrien, Muriel ^a   Belzer, Clara ^b   de Vos, Willem M ^b,c  

^a Groupe Danone   (France)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Akkermansia muciniphila; Akkermansia host interaction; Metabolic disorder; Pre clinical and clinical studies

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAM; FUCOSE; GALACTOSE; IMMUNOGLOBULIN A; METRONIDAZOLE; MUCIN; N ACETYLGALACTOSAMINE; N ACETYLGLUCOSAMINE; NEOMYCIN; SIALIC ACID; SULFATE; ANTIINFECTIVE AGENT;

AKKERMANSIA MUCINIPHILA; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BIOACCUMULATION; DIETARY INTAKE; ENZYME DEGRADATION; ENZYME SYNTHESIS; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; INTESTINE FLORA; METABOLIC DISORDER; MICROBIAL COMMUNITY; NONHUMAN; PERMEABILITY BARRIER; POLYMERASE CHAIN REACTION; POPULATION ABUNDANCE; QUANTITATIVE ANALYSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; ANIMAL; ANIMAL MODEL; CLASSIFICATION; CLINICAL STUDY; DRUG EFFECTS; FECES; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASE; INTESTINE; INTESTINE MUCOSA; METAGENOME; MICROBIOLOGY; MOUSE; OBESITY; PHYLOGENY; PHYSIOLOGY; VERRUCOMICROBIA;

ANIMALS; ANTI-BACTERIAL AGENTS; CLINICAL STUDIES AS TOPIC; FECES; GASTROINTESTINAL MICROBIOME; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; INTESTINES; METABOLIC DISEASES; METAGENOME; MICE; MODELS, ANIMAL; OBESITY; PHYLOGENY; VERRUCOMICROBIA;

EID: 84959083589     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2016.02.005     Document Type: Review

References (125)

1. [1] Rajilić-Stojanović, M., de Vos, W.M., The first 1000 cultured species of the human gastrointestinal microbiota. FEMS Microbiol. Rev. 38 (2014), 996–1047.
2. [2] Hungate, R., The anaerobic mesophilic cellulolytic bacteria. Bacteriol. Rev. 14 (1950), 1–49.
3. [3] Woese, C.R., Fox, G.E., Phylogenetic structure of the prokaryotic domain: the primary kingdoms. Proc. Natl. Acad. Sci. U. S. A. 74 (1977), 5088–5090.
4. [4] Nielsen, H.B., Almeida, M., Juncker, A.S., Rasmussen, S., Li, J., Sunagawa, S., et al. Identification and assembly of genomes and genetic elements in complex metagenomic samples without using reference genomes. Nat. Biotechnol. 32 (2014), 822–828.
5. [5] Di Rienzi, S.C., Sharon, I., Wrighton, K.C., Koren, O., Hug, L.A., Thomas, B.C., et al. The Human Gut and Groundwater Harbor Non-photosynthetic Bacteria Belonging to a New Candidate Phylum Sibling to Cyanobacteria. 2013.
6. [6] Lagier, J.C., Armougom, F., Million, M., Hugon, P., Pagnier, I., Robert, C., et al. Microbial culturomics: paradigm shift in the human gut microbiome study. Clin. Microbiol. Infec 18 (2012), 1185–1193.
7. [7] Lagier, J.-C., Edouard, S., Pagnier, I., Mediannikov, O., Drancourt, M., Raoult, D., Current and past strategies for bacterial culture in clinical microbiology. Clin. Microbiol. Rev. 28 (2015), 208–236.
8. [8] Lagier, J.-C., Hugon, P., Khelaifia, S., Fournier, P.-E., La Scola, B., Raoult, D., The rebirth of culture in microbiology through the example of culturomics to study human gut microbiota. Clin. Microbiol. Rev. 28 (2015), 237–264.
9. [9] Schnupf, P., Gaboriau-Routhiau, V., Gros, M., Friedman, R., Moya-Nilges, M., Nigro, G., et al. Growth and host interaction of mouse segmented filamentous bacteria in vitro. Nature 520 (2015), 99–103.
10. [10] Derrien, M., Vaughan, E.E., Plugge, C.M., de Vos, W.M., Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int. J. Syst. Evol. Microbiol. 54 (2004), 1469–1476.
11. [11] Derrien, M., Collado, M.C., Ben-Amor, K., Salminen, S., de Vos, W.M., The mucin degrader Akkermansia muciniphila is an abundant resident of the human intestinal tract. Appl. Environ. Microbiol. 74 (2008), 1646–1648.
12. [12] Collado, M.C., Derrien, M., Isolauri, E., de Vos, W.M., Salminen, S., Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly. Appl. Environ. Microbiol. 73 (2007), 7767–7770.
13. [13] Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D.R., et al. Enterotypes of the human gut microbiome. Nature 473 (2011), 174–180.
14. [14] Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., et al. Richness of human gut microbiome correlates with metabolic markers. Nature 500 (2013), 541–546.
15. [15] Dao, M.C., Everard, A., Aron-Wisnewsky, J., Sokolovska, N., Prifti, E., Verger, E.O., et al. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut 65:3 (2016 Mar), 426–436, 10.1136/gutjnl-2014-308778.
16. [16] Derrien, M., Van Baarlen, P., Hooiveld, G., Norin, E., Müller, M., de Vos, W., Modulation of mucosal immune response, tolerance, and proliferation in mice colonized by the mucin-degrader Akkermansia muciniphila. Front. Microbiol., 2, 2011, 10.3389/fmicb.2011.00166.
17. [17] Preidis, G.A., Ajami, N.J., Wong, M.C., Bessard, B.C., Conner, M.E., Petrosino, J.F., Composition and function of the undernourished neonatal mouse intestinal microbiome. J. Nutr. Biochem. 26 (2015), 1050–1057.
18. [18] Van den Abbeele, P., Grootaert, C., Marzorati, M., Possemiers, S., Verstraete, W.E., Gérard, P., et al. Microbial community development in a dynamic gut model is reproducible, colon region specific, and selective for Bacteroidetes and Clostridium Cluster IX. Appl. Environ. Microbiol. 76 (2010), 5237–5246.
19. [19] Kemperman, R.A., Gross, G., Mondot, S., Possemiers, S., Marzorati, M., Van de Wiele, T., et al. Impact of polyphenols from black tea and red wine/grape juice on a gut model microbiome. Food Res. Int. 53 (2013), 659–669.
20. [20] Johansson, M.E.V., Phillipson, M., Petersson, J., Velcich, A., Holm, L., Hansson, G.C., The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc. Natl. Acad. Sci. U. S. A. 105 (2008), 15064–15069.
21. [21] Tailford, L., Crost, E., Kavanaugh, D., Juge, N., Mucin glycan foraging in the human gut microbiome. Front. Genet., 6, 2015.
22. [22] Derrien, M., van Passel, M.W.J., van de Bovenkamp, J.H.B., Schipper, R., de Vos, W., Dekker, J., Mucin-bacterial interactions in the human oral cavity and digestive tract. Gut Microbes 1 (2010), 254–268.
23. [23] Berry, D., Stecher, B., Schintlmeister, A., Reichert, J., Brugiroux, S., Wild, B., et al. Host-compound foraging by intestinal microbiota revealed by single-cell stable isotope probing. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 4720–4725.
24. [24] Belzer, C., de Vos, W.M., Microbes inside – from diversity to function: the case of Akkermansia. ISME J. 6 (2012), 1449–1458.
25. [25] Liu, X., Fan, H., Ding, X., Hong, Z., Nei, Y., Liu, Z., et al. Analysis of the gut microbiota by high-throughput sequencing of the V5–V6 regions of the 16S rRNA gene in donkey. Curr. Microbiol. 68 (2014), 657–662.
26. [26] Zeng, B., Han, S., Wang, P., Wen, B., Jian, W., Guo, W., et al. The bacterial communities associated with fecal types and body weight of rex rabbits. Sci. Rep., 5, 2015.
27. [27] Sonoyama, K., Fujiwara, R., Takemura, N., Ogasawara, T., Watanabe, J., Ito, H., et al. Response of gut microbiota to fasting and hibernation in Syrian hamsters. Appl. Environ. Microbiol. 75 (2009), 6451–6456.
28. [28] Costello, E.K., Gordon, J.I., Secor, S.M., Knight, R., Postprandial remodeling of the gut microbiota in Burmese pythons. ISME J. 4 (2010), 1375–1385.
29. [29] Rodriguez, C., Taminiau, B., Brevers, B., Avesani, V., Van Broeck, J., Leroux, A., et al. Faecal microbiota characterisation of horses using 16 rdna barcoded pyrosequencing, and carriage rate of clostridium difficile at hospital admission. BMC Microbiol., 15, 2015, 181.
30. [30] Costa, M.C., Stämpfli, H.R., Allen-Vercoe, E., Weese, J.S., Development of the faecal microbiota in foals. Equine Vet. J., 2015 n/a-n/a.
31. [31] Kanengoni, A., Chimonyo, M., Tasara, T., Cormican, P., Chapwanya, A., Ndimba, B., et al. A comparison of faecal microbial populations of South African Windsnyer-type indigenous pigs (SAWIPs) and large white × landrace (LW × LR) crosses fed diets containing ensiled maize cobs. FEMS Microbiol. Lett., 362, 2015.
32. [32] Ushida, K., Segawa, T., Tsuchida, S., Murata, K., Cecal bacterial communities in wild Japanese rock ptarmigans and captive Svalbard rock ptarmigans. J. Vet. Med. Sci., 2015 advpub.
33. [33] Png, C.W., Linden, S.K., Gilshenan, K.S., Zoetendal, E.G., McSweeney, C.S., Sly, L.I., et al. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am. J. Gastroenterol. 105 (2010), 2420–2428.
34. [34] Tailford, L.E., Owen, C.D., Walshaw, J., Crost, E.H., Hardy-Goddard, J., Le Gall, G., et al. Discovery of intramolecular trans-sialidases in human gut microbiota suggests novel mechanisms of mucosal adaptation. Nat. Commun., 6, 2015.
35. [35] Cheng, J., Ringel-Kulka, T., Heikamp-de Jong, I., Ringel, Y., Carroll, I., de Vos, W.M., et al. Discordant temporal development of bacterial phyla and the emergence of core in the fecal microbiota of young children. ISME J., 2015.
36. [36] Grześkowiak, Ł., Grönlund, M.-M., Beckmann, C., Salminen, S., von Berg, A., Isolauri, E., The impact of perinatal probiotic intervention on gut microbiota: double-blind placebo-controlled trials in Finland and Germany. Anaerobe 18 (2012), 7–13.
37. [37] Collado, M.C., Laitinen, K., Salminen, S., Isolauri, E., Maternal weight and excessive weight gain during pregnancy modify the immunomodulatory potential of breast milk. Pediatr. Res. 72 (2012), 77–85.
38. [38] Urbaniak, C., Cummins, J., Brackstone, M., Macklaim, J.M., Gloor, G.B., Baban, C.K., et al. Microbiota of human breast tissue. Appl. Environ. Microbiol. 80 (2014), 3007–3014.
39. [39] Azad, M.B., Konya, T., Maughan, H., Guttman, D.S., Field, C.J., Chari, R.S., et al. Gut microbiota of healthy Canadian infants: profiles by mode of delivery and infant diet at 4 months. CMAJ 185 (2013), 385–394.
40. [40] Bergström, A., Skov, T.H., Bahl, M.I., Roager, H.M., Christensen, L.B., Ejlerskov, K.T., et al. Establishment of intestinal microbiota during early life: a longitudinal, explorative study of a large cohort of Danish infants. Appl. Environ. Microbiol. 80 (2014), 2889–2900.
41. [41] Biagi, E., Nylund, L., Candela, M., Ostan, R., Bucci, L., Pini, E., et al. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One, 5, 2010, e10667.
42. [42] Wang, F., Yu, T., Huang, G., Cai, D., Liang, X., Su, H., et al. Gut microbiota community and its assembly associated with age and diet in Chinese centenarians. J. Microbiol. Biotechnol., 24, 2014.
43. [43] Wacklin, P., Tuimala, J., Nikkilä, J., Sebastian, T., Mäkivuokko, H., Alakulppi, N., et al. Faecal microbiota composition in adults is associated with the FUT2 gene determining the secretor status. PLoS One, 9, 2014, e94863.
44. [44] Ellekilde, M., Krych, L., Hansen, C.H.F., Hufeldt, M.R., Dahl, K., Hansen, L.H., et al. Characterization of the gut microbiota in leptin deficient obese mice – correlation to inflammatory and diabetic parameters. Res. Vet. Sci. 96 (2014), 241–250.
45. [45] Zhang, H., Sparks, J.B., Karyala, S.V., Settlage, R., Luo, X.M., Host adaptive immunity alters gut microbiota. ISME J. 9 (2015), 770–781.
46. [46] Nguyen, T.L.A., Vieira-Silva, S., Liston, A., Raes, J., How informative is the mouse for human gut microbiota research?. Dis. Model Mech. 8 (2015), 1–16.
47. [47] Roopchand, D.E., Carmody, R.N., Kuhn, P., Moskal, K., Rojas-Silva, P., Turnbaugh, P.J., et al. Dietary polyphenols promote growth of the gut bacterium Akkermansia muciniphila and attenuate high fat diet-induced metabolic syndrome. Diabetes, 2015.
48. [48] Anhê, F.F., Roy, D., Pilon, G., Dudonné, S., Matamoros, S., Varin, T.V., et al. A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice. Gut 64 (2015), 872–883.
49. [49] Everard, A., Lazarevic, V., Derrien, M., Girard, M., Muccioli, G.G., Neyrinck, A.M., et al. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 60 (2011), 2775–2786.
50. [50] Reid, D., Eller, L., Nettleton, J., Reimer, R., Postnatal prebiotic fibre intake mitigates some detrimental metabolic outcomes of early overnutrition in rats. Eur. J. Nutr., 2015, 1–11.
51. [51] Chaplin, A., Parra, P., Serra, F., Palou, A., Conjugated linoleic acid supplementation under a high-fat diet modulates stomach protein expression and intestinal microbiota in adult mice. PLoS One, 10, 2015, e0125091.
52. [52] Andersson, K., Axling, U., Xu, J., Swärd, K., Ahrné, S., Molin, G., et al. Diverse effects of oats on cholesterol metabolism in C57BL/6 mice correlate with expression of hepatic bile acid-producing enzymes. Eur. J. Nutr. 52 (2013), 1755–1769.
53. [53] Sybille, T., June, Z., Michael, K., Roy, M., Maria, L.M., The intestinal microbiota in aged mice is modulated by dietary resistant starch and correlated with improvements in host responses. FEMS Microbiol. Ecol. 83 (2013), 299–309.
54. [54] Halmos, E.P., Christophersen, C.T., Bird, A.R., Shepherd, S.J., Gibson, P.R., Muir, J.G., Diets that differ in their FODMAP content alter the colonic luminal microenvironment. Gut 64 (2015), 93–100.
55. [55] Zhong, Y., Nyman, M., Fåk, F., Modulation of gut microbiota in rats fed high-fat diets by processing whole-grain barley to barley malt. Mol. Nutr. Food Res., 2015 n/a-n/a.
56. [56] Gómez-Gallego, C., Collado, M.C., Ilo, T., Jaakkola, U.-M., Bernal, M.J., Periago, M.J., et al. Infant formula supplemented with polyamines alters the intestinal microbiota in neonatal BALB/cOlaHsd mice. J. Nutr. Biochem. 23 (2012), 1508–1513.
57. [57] Gómez-Gallego, C., Collado, M.C., Pérez, G., Ilo, T., Jaakkola, U.-M., Bernal, M.J., et al. Resembling breast milk: influence of polyamine-supplemented formula on neonatal BALB/cOlaHsd mouse microbiota. Br. J. Nutr. 111 (2014), 1050–1058.
58. [58] Song, H., Chu, Q., Yan, F., Yang, Y., Han, W., Zheng, X., Red pitaya betacyanins protects from diet-induced obesity, liver steatosis and insulin resistance in association with modulation of gut microbiota in mice. J. Gastroenterol. Hepatol., 2015 (n/a-n/a).
59. [59] Alard, J., Lehrter, V., Rhimi, M., Mangin, I., Peucelle, V., Abraham, A.-L., et al. Beneficial metabolic effects of selected probiotics on diet-induced obesity and insulin resistance in mice are associated with improvement of dysbiotic gut microbiota. Environ. Microbiol., 2015 (n/a-n/a).
60. [60] Yang, J., Bindels, L.B., Segura Munoz, R.R., Martínez, I., Walter, J., Ramer-Tait, A.E., et al. Disparate metabolic responses in mice fed a high-fat diet supplemented with maize-derived non-digestible feruloylated oligo- and polysaccharides are linked to changes in the gut microbiota. PLoS One, 11, 2016, e0146144.
61. [61] Wang, J.-H., Bose, S., Kim, G.-C., Hong, S.-U., Kim, J.-H., Kim, J-e, et al. Flos Lonicera ameliorates obesity and associated endotoxemia in rats through modulation of gut permeability and intestinal microbiota. PLoS One, 9, 2014, e86117.
62. [62] Wang, J.-H., Bose, S., Kim, H.-G., Han, K.-S., Kim, H., Fermented Rhizoma Atractylodis Macrocephalae alleviates high fat diet-induced obesity in association with regulation of intestinal permeability and microbiota in rats. Sci. Rep., 5, 2015.
63. [63] Chang, C.-J., Lin, C.-S., Lu, C.-C., Martel, J., Ko, Y.-F., Ojcius, D.M., et al. Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. Nat. Commun., 6, 2015.
64. [64] Jakobsdottir, G., Xu, J., Molin, G., Ahrné, S., Nyman, M., High-fat diet reduces the formation of butyrate, but increases succinate, inflammation, liver fat and cholesterol in rats, while dietary fibre counteracts these effects. PLoS One, 8, 2013, e80476.
65. [65] Baldwin, J., Collins, B., Wolf, P.G., Martinez, K., Shen, W., Chuang, C.-C., et al. Table grape consumption reduces adiposity and markers of hepatic lipogenesis and alters gut microbiota in butter fat-fed mice. J. Nutr. Biochem., 2015.
66. [66] Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J.P., Druart, C., Bindels, L.B., et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 9066–9071.
67. [67] Shin, N.-R., Lee, J.-C., Lee, H.-Y., Kim, M.-S., Whon, T.W., Lee, M.-S., et al. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut 63 (2014), 727–735.
68. [68] Lee, H., Ko, G., Effect of metformin on metabolic improvement and gut microbiota. Appl. Environ. Microbiol. 80 (2014), 5935–5943.
69. [69] Sands, S., Tsau, S., Yankee, T., Parker, B., Ericsson, A., LeVine, S., The effect of omeprazole on the development of experimental autoimmune encephalomyelitis in C57BL/6J and SJL/J mice. BMC Res. Notes, 7, 2014, 605.
70. [70] DE. Freedberg, NC. Toussaint, SP. Chen, AJ. Ratner, S. Whittier, TC Wang, et al. Proton pump inhibitors alter specific taxa in the human gastrointestinal microbiome: a crossover trial. Gastroenterology.149:883–5.e9.
71. [71] Nobel, Y.R., Cox, L.M., Kirigin, F.F., Bokulich, N.A., Yamanishi, S., Teitler, I., et al. Metabolic and metagenomic outcomes from early-life pulsed antibiotic treatment. Nat. Commun., 6, 2015.
72. [72] Dubourg, G., Lagier, J.-C., Armougom, F., Robert, C., Audoly, G., Papazian, L., et al. High-level colonisation of the human gut by Verrucomicrobia following broad-spectrum antibiotic treatment. Int. J. Antimicrob. Agents 41 (2013), 149–155.
73. [73] Caputo, A., Dubourg, G., Croce, O., Gupta, S., Robert, C., Papazian, L., et al. Whole-genome assembly of Akkermansia muciniphila sequenced directly from human stool. Biol. Direct, 10, 2015, 5.
74. [74] Vrieze, A., Out, C., Fuentes, S., Jonker, L., Reuling, I., Kootte, R.S., et al. Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity. J. Hepatol. 60 (2014), 824–831.
75. [75] Ferrer, M., Martins dos Santos, V.A.P., Ott, S.J., Moya, A., Gut microbiota disturbance during antibiotic therapy. Gut Microbes 5 (2013), 64–70.
76. [76] Hernández, E., Bargiela, R., Diez, M.S., Friedrichs, A., Pérez-Cobas, A.E., Gosalbes, M.J., et al. Functional consequences of microbial shifts in the human gastrointestinal tract linked to antibiotic treatment and obesity. Gut Microbes 4 (2013), 306–315.
77. [77] Hansen, C.H.F., Krych, L., Nielsen, D.S., Vogensen, F.K., Hansen, L.H., Sørensen, S.J., et al. Early life treatment with vancomycin propagates Akkermansia muciniphila and reduces diabetes incidence in the NOD mouse. Diabetologia 55 (2012), 2285–2294.
78. [78] Cani, P.D., Amar, J., Iglesias, M.A., Poggi, M., Knauf, C., Bastelica, D., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56 (2007), 1761–1772.
79. [79] Rosenbaum, M., Knight, R., Leibel, R.L., The gut microbiota in human energy homeostasis and obesity. Trends Endocrinol. Metabolism 26 (2015), 493–501.
80. [80] Ridaura, V.K., Faith, J.J., Rey, F.E., Cheng, J., Duncan, A.E., Kau, A.L., et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science, 341, 2013.
81. [81] Bäckhed, F., Ding, H., Wang, T., Hooper, L.V., Koh, G.Y., Nagy, A., et al. The gut microbiota as an environmental factor that regulates fat storage. Proc. Nat. Acad. Sci. U. S. A. 101 (2004), 15718–15723.
82. [82] A. Vrieze, E. Van Nood, F. Holleman, J. Salojärvi, RS. Kootte, JFWM. Bartelsman, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology.143:913–6.e7.
83. [83] M. Cox Laura, S. Yamanishi, J. Sohn, V. Alekseyenko Alexander, M. Leung Jacqueline, I. Cho, et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell.158:705–721.
84. [84] Liou, A.P., Paziuk, M., Luevano, J.-M., Machineni, S., Turnbaugh, P.J., Kaplan, L.M., Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci. Transl. Med. 5 (2013), 178–241.
85. [85] Zhang, H., DiBaise, J.K., Zuccolo, A., Kudrna, D., Braidotti, M., Yu, Y., et al. Human gut microbiota in obesity and after gastric bypass. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 2365–2370.
86. [86] Org, E., Parks, B.W.W., Joo, J.W.J., Emert, B., Schwartzman, W., Kang, E.Y., et al. Genetic and environmental control of host-gut microbiota interactions. Genome Res. 25 (2015), 1558–1569.
87. [87] Chevalier, C., Stojanović, O., Colin Didier, J., Suarez-Zamorano, N., Tarallo, V., Veyrat-Durebex, C., et al. Gut microbiota orchestrates energy homeostasis during cold. Cell. 163 (2015), 1360–1374.
88. [88] Zhong, Y., Marungruang, N., Fåk, F., Nyman, M., Effects of two whole-grain barley varieties on caecal SCFA, gut microbiota and plasma inflammatory markers in rats consuming low- and high-fat diets. Br. J. Nutr., 2015 FirstView:1–13.
89. [89] Fåk, F., Jakobsdottir, G., Kulcinskaja, E., Marungruang, N., Matziouridou, C., Nilsson, U., et al. The physico-chemical properties of dietary fibre determine metabolic responses, short-chain fatty acid profiles and gut microbiota composition in rats fed low- and high-fat diets. PLoS One, 10, 2015, e0127252.
90. [90] Hamilton, M.K., Boudry, G., Lemay, D.G., Raybould, H.E., Changes in intestinal barrier function and gut microbiota in high-fat diet-fed rats are dynamic and region dependent. Am. J. Physiol. Gastrointest. Liver Physiol. 308 (2015), G840–G851.
91. [91] Carmody Rachel, N., Gerber Georg, K., Luevano Jesus, M. Jr., Gatti Daniel, M., Somes, L., Svenson Karen, L., et al. Diet dominates host genotype in shaping the murine gut microbiota. Cell Host Microbe 17 (2015), 72–84.
92. [92] Karlsson, C.L.J., Önnerfält, J., Xu, J., Molin, G., Ahrné, S., Thorngren-Jerneck, K., The microbiota of the gut in preschool children with normal and excessive body weight. Obesity 20 (2012), 2257–2261.
93. [93] Teixeira, T.F.S., Grześkowiak, Ł.M., Salminen, S., Laitinen, K., Bressan, J., Gouveia Peluzio, MdC., Faecal levels of Bifidobacterium and Clostridium coccoides but not plasma lipopolysaccharide are inversely related to insulin and HOMA index in women. Clin. Nutr. 32 (2013), 1017–1022.
94. [94] Remely, M., Tesar, I., Hippe, B., Gnauer, S., Rust, P., Haslberger, A.G., Gut microbiota composition correlates with changes in body fat content due to weight loss. Benef. Microbes 6 (2015), 431–439.
95. [95] Escobar, J.S., Klotz, B., Valdes, B., Agudelo, G., The gut microbiota of Colombians differs from that of Americans. Eur. Asians. BMC Microbiol, 14, 2014.
96. [96] Brahe, L.K., Le Chatelier, E., Prifti, E., Pons, N., Kennedy, S., Hansen, T., et al. Specific gut microbiota features and metabolic markers in postmenopausal women with obesity. Nutr. Diabetes, 5, 2015, e159.
97. [97] Santacruz, A., Collado, M.C., García-Valdés, L., Segura, M.T., Martín-Lagos, J.A., Anjos, T., et al. Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women. Br. J. Nutr. 104 (2010), 83–92.
98. [98] Collado, M.C., Isolauri, E., Laitinen, K., Salminen, S., Effect of mother's weight on infant's microbiota acquisition, composition, and activity during early infancy: a prospective follow-up study initiated in early pregnancy. Am. J. Clin. Nutr. 92 (2010), 1023–1030.
99. [99] Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490 (2012), 55–60.
100. [100] Forslund, K., Hildebrand, F., Nielsen, T., Falony, G., Le Chatelier, E., Sunagawa, S., et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 528 (2015), 262–266.
101. [101] Håkansson, Å., Tormo-Badia, N., Baridi, A., Xu, J., Molin, G., Hagslätt, M.L., et al. Immunological alteration and changes of gut microbiota after dextran sulfate sodium (DSS) administration in mice. Clin. Exp. Med. 15 (2015), 107–120.
102. [102] Reikvam, D.H., Derrien, M., Islam, R., Erofeev, A., Grcic, V., Sandvik, A., et al. Epithelial-microbial crosstalk in polymeric Ig receptor deficient mice. Eur. J. Immunol. 42 (2012), 2959–2970.
103. [103] Berry, D., Schwab, C., Milinovich, G., Reichert, J., Ben Mahfoudh, K., Decker, T., et al. Phylotype-level 16S rRNA analysis reveals new bacterial indicators of health state in acute murine colitis. ISME J. 6 (2012), 2091–2106.
104. [104] Berry, D., Kuzyk, O., Rauch, I., Heider, S., Schwab, C., Hainzl, E., et al. Intestinal microbiota signatures associated with inflammation history in mice experiencing recurring colitis. Front. Microbiol., 6, 2015.
105. [105] C-s, Kang, Ban, M., Choi, E.-J., Moon, H.-G., Jeon, J.-S., Kim, D.-K., et al. Extracellular vesicles derived from gut microbiota, especially Akkermansia muciniphila, protect the progression of dextran sulfate sodium-induced colitis. PLoS One, 8, 2013, e76520.
106. [106] Rajilic-Stojanovic, M., Shanahan, F., Guarner, F., de Vos, W.M., Phylogenetic analysis of dysbiosis in ulcerative colitis during remission. Inflamm. Bowel Dis. 19 (2013), 481–488.
107. [107] Swidsinski, A., Dörffel, Y., Loening-Baucke, V., Theissig, F., Rückert, J.C., Ismail, M., et al. Acute appendicitis is characterised by local invasion with Fusobacterium nucleatum/necrophorum. Gut 60 (2011), 34–40.
108. [108] Loonen, L.M., Stolte, E.H., Jaklofsky, M.T., Meijerink, M., Dekker, J., van Baarlen, P., et al. REG3[gamma]-deficient mice have altered mucus distribution and increased mucosal inflammatory responses to the microbiota and enteric pathogens in the ileum. Mucosal Immunol. 7 (2014), 939–947.
109. [109] Van den Abbeele, P., Gérard, P., Rabot, S., Bruneau, A., El Aidy, S., Derrien, M., et al. Arabinoxylans and inulin differentially modulate the mucosal and luminal gut microbiota and mucin-degradation in humanized rats. Environ. Microbiol. 13 (2011), 2667–2680.
110. [110] Earle Kristen, A., Billings, G., Sigal, M., Lichtman Joshua, S., Hansson Gunnar, C., Elias Joshua, E., et al. Quantitative imaging of gut microbiota spatial organization. Cell Host Microbe 18 (2015), 478–488.
111. [111] Ijssennagger, N., Belzer, C., Hooiveld, G.J., Dekker, J., van Mil, S.W.C., Müller, M., et al. Gut microbiota facilitates dietary heme-induced epithelial hyperproliferation by opening the mucus barrier in colon. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 10038–10043.
112. [112] Lukovac, S., Belzer, C., Pellis, L., Keijser, B.J., de Vos, W.M., Montijn, R.C., et al. Differential modulation by Akkermansia muciniphila and Faecalibacterium prausnitzii of host peripheral lipid metabolism and histone acetylation in mouse gut organoids. mBio 5 (2014), e01438–e01514.
113. [113] Alexander, K.L., Targan, S.R., Elson, C.O., Microbiota activation and regulation of innate and adaptive immunity. Immunol. Rev. 260 (2014), 206–220.
114. [114] AJ. Macpherson, Y. Köller, KD. McCoy. The bilateral responsiveness between intestinal microbes and IgA. Trends Immunol. 36:460–470.
115. [115] Mathias, A., Pais, B., Favre, L., Benyacoub, J., Corthésy, B., Role of secretory IgA in the mucosal sensing of commensal bacteria. Gut Microbes 5 (2014), 688–695.
116. [116] Kau, A.L., Planer, J.D., Liu, J., Rao, S., Yatsunenko, T., Trehan, I., et al. Functional characterization of IgA-targeted bacterial taxa from undernourished Malawian children that produce diet-dependent enteropathy. Sci. Transl. Med. 7 (2015), 276–324.
117. [117] Reunanen, J., Kainulainen, V., Huuskonen, L., Ottman, N., Belzer, C., Huhtinen, H., et al. Akkermansia muciniphila adheres to enterocytes and strengthens the integrity of epithelial cell layer. Appl. Environ. Microbiol., 2015.
118. [118] Ganesh, B.P., Klopfleisch, R., Loh, G., Blaut, M., Commensal Akkermansia muciniphila exacerbates gutiInflammation in Salmonella Typhimurium-infected gnotobiotic mice. PLoS One, 8, 2013, e74963x.
119. [119] Kankainen, M., Paulin, L., Tynkkynen, S., von Ossowski, I., Reunanen, J., Partanen, P., et al. Comparative genomic analysis of Lactobacillus rhamnosus GG reveals pili containing a human- mucus binding protein. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 17193–17198.
120. [120] Earley, H., Lennon, G., Balfe, A., Kilcoyne, M., Clyne, M., Joshi, L., et al. A preliminary study examining the binding capacity of Akkermansia muciniphila and Desulfovibrio spp., to colonic mucin in health and ulcerative colitis. PLoS One, 10, 2015, e0135280.
121. [121] van Passel, M.W.J., Kant, R., Zoetendal, E.G., Plugge, C.M., Derrien, M., Malfatti, S.A., et al. The Genome of Akkermansia muciniphila, a dedicated intestinal mucin degrader, and its use in exploring intestinal metagenomes. PLoS One, 6, 2011, e16876.
122. [122] Clarke, S.F., Murphy, E.F., O'Sullivan, O., Lucey, A.J., Humphreys, M., Hogan, A., et al. Exercise and associated dietary extremes impact on gut microbial diversity. Gut 63 (2014), 1913–1920.
123. [123] Kim, B.-S., Song, M-y, Kim, H., The anti-obesity effect of Ephedra sinica through modulation of gut microbiota in obese Korean women. J. Ethnopharmacol. 152 (2014), 532–539.
124. [124] Remely, M., Hippe, B., Geretschlaeger, I., Stegmayer, S., Hoefinger, I., Haslberger, A., Increased gut microbiota diversity and abundance of Faecalibacterium prausnitzii and Akkermansia after fasting: a pilot study. Wien Klin. Wochenschr., 2015, 1–5.
125. [125] Zhang, X., Shen, D., Fang, Z., Jie, Z., Qiu, X., Zhang, C., et al. Human gut microbiota changes reveal the progression of glucose intolerance. PLoS One, 8, 2013, e71108.